Prof Paul Declerck speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about the regulatory principles that lead to the approval of biosimilars.

He describes the main steps of this stringent process, along with the similarities seen in other countries.

Prof Declerck also outlines possible improvements that may also enhance this process.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.